These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6173886)

  • 41. Long-term effects of 5,7-dihydroxytryptamine on brain monoamines.
    Jacoby JH; Lytle LD; Nelson MF
    Life Sci; 1974 Mar; 14(5):909-19. PubMed ID: 4828406
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of selective adrenoceptor agonists and antagonists on aggressive behavior elicited by apomorphine, DL-dopa and fusaric acid in REM-sleep-deprived rats.
    Troncone LR; Tufik S
    Physiol Behav; 1991 Jul; 50(1):173-8. PubMed ID: 1946713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain monoamine levels and E1 mouse convulsions.
    Hiramatsu M
    Folia Psychiatr Neurol Jpn; 1981; 35(3):261-6. PubMed ID: 6173293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of locomotor activity and catecholamine and 5-hydroxytryptamine metabolism by thyrotropin releasing hormone.
    Agarwal RA; Rastogi RB; Singhal RL
    Neuroendocrinology; 1977; 23(4):236-47. PubMed ID: 409963
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacological action of FD-008, a new dopamine beta-hydroxylase inhibitor. I. Effects on blood pressure in rats and dogs.
    Ishii Y; Fujii Y; Mimura Ch; Umezawa H
    Arzneimittelforschung; 1975 Jan; 25(1):55-9. PubMed ID: 1173769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
    de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
    Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chromium picolinate.
    Reading SA
    J Fla Med Assoc; 1996 Jan; 83(1):29-31. PubMed ID: 8849977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estradiol modulation of central monoamine activity in female mountain spiny lizards.
    Woodley SK; Matt KS; Moore MC
    Brain Behav Evol; 2000 Oct; 56(4):175-83. PubMed ID: 11154996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nerve growth factor: effects on D-amphetamine-induced activity and brain monoamines.
    Lewis ME; Brown RM; Brownstein MJ; Hart T; Stein DG
    Brain Res; 1979 Nov; 176(2):297-310. PubMed ID: 40668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion.
    Robinson TE; Camp DM
    Pharmacol Biochem Behav; 1987 Apr; 26(4):821-7. PubMed ID: 2440058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Psychopharmacological study of enkephalins, with special reference to the relation between behavioral profiles and brain monoamines].
    Kameyama T; Ukai M; Noma S
    Yakubutsu Seishin Kodo; 1981 Oct; 1(1):21-8. PubMed ID: 6198817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of fusaric acid on the membrane potential in left ventricle fragments from rats and rabbits.
    Richter R
    Pharmazie; 1982 Oct; 37(10):736. PubMed ID: 7178221
    [No Abstract]   [Full Text] [Related]  

  • 54. Time-dependent changes in brain biogenic amine dynamics following castration in male rats.
    Bernard BK; Paolino RM
    J Neurochem; 1974 Jun; 22(6):951-6. PubMed ID: 4859566
    [No Abstract]   [Full Text] [Related]  

  • 55. Withdrawal from repeated administration of a low dose of reserpine induced opposing adaptive changes in the noradrenaline and serotonin system function: a behavioral and neurochemical ex vivo and in vivo studies in the rat.
    Antkiewicz-Michaluk L; Wąsik A; Możdżeń E; Romańska I; Michaluk J
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():146-54. PubMed ID: 25445479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effects of fusaric acid and its derivative on the cardiovascular system].
    Furuta Y; Washizaki M
    Nihon Yakurigaku Zasshi; 1976 Mar; 72(2):139-44. PubMed ID: 987962
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of guanidinoethanesulfonic acid on brain monoamines in the mouse.
    Watanabe Y; Watanabe S; Yokoi I; Mori A
    Neurochem Res; 1991 Oct; 16(10):1149-54. PubMed ID: 1724553
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurochemical correlates of behaviour--content of tryptophan, 5-hydroxytryptophan, serotonin, 5-hydroxyindoleacetic acid, tyrosine, dopamine and norepinephrine in four brain parts of the pigeon during behavioural depression following an injection of tryptophan.
    Smith JE; Hingtgen JN; Lane JD; Aprison MH
    J Neurochem; 1976 Mar; 26(3):537-41. PubMed ID: 4584
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of dietary tyrosine, phenylalanine, and tryptophan on aggression in mice.
    Thurmond JB; Lasley SM; Conkin AL; Brown JW
    Pharmacol Biochem Behav; 1977 Apr; 6(4):475-8. PubMed ID: 560699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proceedings: Brain monoamines and the increase in motor activity in the rat after amphetamine.
    Guldberg HC; Marsden CA
    Br J Pharmacol; 1972 Feb; 44(2):347P-348P. PubMed ID: 4668615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.